| Document |
Document Title |
|
WO/2023/196312A1 |
Embodiments of the present disclosure are directed to radiopaque polymer formulations comprising thermoplastic polymer and a filler. The filler comprises 25 wt% to 45 wt% of tungsten and 35 wt% to 55 wt% of barium sulfate.
|
|
WO/2023/185379A1 |
The present invention provides a nerve conduit loaded with adipose-derived stem cells and a preparation method therefor. The preparation method comprises: S1, adding polycaprolactone and polyvinylpyrrolidone into a binary organic solvent...
|
|
WO/2023/182121A1 |
The present invention provides: a resin composition which emits near-infrared fluorescence at a high luminescent efficiency and is relatively easy to produce; and a method for producing a molded object from the resin composition. Also pr...
|
|
WO/2023/178519A1 |
A drug coating, a drug balloon, a preparation method for the drug balloon and use thereof. The drug coating for use in the drug balloon comprises a drug and a carrier, the carrier being a phenolic compound or a pyrone compound, and the m...
|
|
WO/2023/177596A1 |
Flexible high-pressure angioplasty balloons are disclosed herein which utilize an inflatable balloon positioned upon the catheter and a supporting structure secured over or along the catheter at a first location proximal to the balloon a...
|
|
WO/2023/176182A1 |
The purpose of the present invention is to provide a balloon for balloon catheters, which can be easily prevented from the breakage in the peripheral direction even when the balloon is broken.　Provided is a balloon (20) for balloon cat...
|
|
WO/2023/172876A1 |
A method of generating monodispersed and homogenous microspheres comprising sirolimus is disclosed. The method can include producing sirolimus droplets using microfluidic step emulsification. The sirolimus droplets can include a drug loa...
|
|
WO/2023/170411A1 |
The invention provides an A-B block copolymer amphiphilic additive comprising a hydrophobic hydrocarbon A-block and a hydrophilic poly (alkylene oxide) B-block, wherein the B-block is end-capped with a moiety that is negatively charged o...
|
|
WO/2023/169858A1 |
The invention relates to a method for creating visibility-enhancing markers which can be applied onto a wide variety of materials with a very high degree of geometric variability and which can be used both for radiological as well as for...
|
|
WO/2023/170412A1 |
The invention provides an intermittent catheter comprising a hollow polymeric tubular body comprising a polymer that is negatively charged or that becomes negatively charged when wetted with an aqueous medium having a pH greater than 2, ...
|
|
WO/2023/160630A1 |
A drug eluting balloon loaded with a drug in bulk, without any extra coating to host the said drug, and the method of preparing a drug eluting balloon which directly loads the drug on the balloon without coating, by using supercritical c...
|
|
WO/2023/162926A1 |
This medical coating agent comprises a polymer including a structural unit (A) derived from an ethylenic unsaturated monomer having a urea bond. The polymer contained in the medical coating agent satisfies Condition (i) in a case where a...
|
|
WO/2023/158648A1 |
Methods for applying a therapeutic agent coating to an extended-wear device and the systems created thereby are disclosed. For example, a method for coating an extended-wear device using N-TIPS provides therapeutic agent coating for loca...
|
|
WO/2023/148105A1 |
Disclosed are drug delivery devices, coatings, and microparticles that achieve sufficiently small particle sizes with high loading of Rapamycin. In an embodiment, a balloon comprises a coating on its exterior surface, the coating compris...
|
|
WO/2023/147102A1 |
Profiled drug-coated balloons for nanoparticle-based drug delivery having a reduced-diameter central balloon portion and methods of drug delivery using same are disclosed. The profiled drug-coated balloon may comprise: distal and proxima...
|
|
WO/2023/141237A1 |
Disclosed herein are implantable and non-implantable devices coated with an anti-TRAP agent. A system is also disclosed comprising an implantable device or a non-implantable device and a tissue-injectable/infusible liquid, oil or gel com...
|
|
WO/2023/129132A1 |
Embodiments disclosed herein are directed to a subcutaneous vascular access system including an access port, a catheter, and a cathlock, and including a coating disposed on a surface thereof. The coating can include a lubricious and/or h...
|
|
WO/2023/125100A1 |
The present invention relates to a material surface modification method and a surface modified material obtained based on the method. The method of the present invention comprises the following steps: (1) dissolving, suspending or disper...
|
|
WO/2023/122846A1 |
The invention provides a material made of silicone functionalised with PEG-coated (pegylated) copper nanoparticles that enables bacterial load and biofilm formation to be reduced. The material according to the invention can be used to pr...
|
|
WO/2023/129866A1 |
In a method of integrating an active pharmaceutical ingredient (API) with a thermoplastic polymer, the thermoplastic polymer and API are into a first feed port of a multi-screw extruder or the thermoplastic polymer is fed into the first ...
|
|
WO/2023/103404A1 |
Provided is a preparation method for a tube. The method comprises the following steps: a) adding a polymer solution into a poor solvent, such that the polymer diffuses on the liquid level of the poor solvent, so as to obtain a polymer fi...
|
|
WO/2023/107703A1 |
An object to this invention is to provide a needleless connector having a normally - closed valve with an internal tube segment positioned within the internal fluid flow of the valve, the tube segment having antimicrobial properties such...
|
|
WO/2023/108160A1 |
Molecular iodine-infused catheters disclosed herein have biocidal effects and may be used to treat or prevent urinary tract infection (UTI). Other molecular iodine-infused polymers, articles, and products, and their preparation and uses ...
|
|
WO/2023/100154A1 |
A catheter and method for producing a catheter having an inner layer having a polyolefin- or polyethylene-based thermoplastic elastomeric material; an outer layer; and a tie layer disposed between the inner layer and the outer layer. The...
|
|
WO/2023/100827A1 |
Provided is a medical device that can achieve both of biocompatibility and physical properties and contains a polyurethane resin elastomer. The medical device according to an embodiment includes a polyurethane resin elastomer and water c...
|
|
WO/2023/102436A1 |
Medical articles formed from ionically bonding an ionic polymer and an active agent provide enhanced properties. The ionic polymer may be one or more of an anionic polymer, a cationic polymer, and a zwitterionic polymer. The device may a...
|
|
WO/2023/102437A1 |
Medical articles formed from ionically bonding an ionic polymer and an active agent provide enhanced properties. The ionic polymer may be one or more of an anionic polymer, a cationic polymer, and a zwitterionic polymer. The device may a...
|
|
WO/2023/091475A1 |
A method of treating a recurring airway stricture or stenosis in a body lumen includes inserting a scope and a drug-coated balloon catheter into a target site comprising the recurring airway stricture or stenosis in the body lumen. The m...
|
|
WO/2023/090291A1 |
According to the present invention, rare-earth ferrite containing a rare-earth element, iron, and oxygen is used as an antiviral agent. Specifically, rare-earth ferrite containing a rare-earth element, iron, and oxygen is used as a main ...
|
|
WO/2023/089206A1 |
A multi-layered coating for coating a surface of an implant (20), the multi-layered coating comprising polyelectrolyte layers (13), wherein the polyelectrolyte layers (13) are interspersed layers of a layer that comprises hyaluronic acid...
|
|
WO/2023/089010A1 |
The invention relates to a bacterial nanocellulose and shaped elements made of bacterial nanocellulose and a method for producing the same.
|
|
WO/2023/087001A1 |
A drug-releasing polymer composition is disclosed. It may include a major component, which may be ethylene vinyl acetate, and may further include at least one or two release- modifying materials, and may further include at least one or t...
|
|
WO/2023/083086A1 |
Provided in the present invention are a drug-coated and drug-eluting balloon catheter, and a preparation method therefor. The method comprises: encapsulating a drug with biological material to prepare microspheres, mixing the microsphere...
|
|
WO/2023/085121A1 |
The purpose of the present invention is to provide: a polydimethylacrylamide powder that has very good solubility in various solvents and other manufacturing raw materials and can manifest remarkable hydrophilicity, lubricity, and transp...
|
|
WO/2023/079076A1 |
The invention relates to a medical product, in particular in the form of a balloon catheter, having at least one multi-layer structure that comprises the following layers lying one on top of each other: - at least one metal layer, and - ...
|
|
WO/2023/079290A1 |
A coating composition for application to an expandable medical device comprising a polymeric compound comprising a central portion and two end portions wherein either the central portion is hydrophobic and the end portions are hydrophili...
|
|
WO/2023/076408A1 |
Medical tubing has at least one layer having a composition prepared from a melt blend of (i) a thermoplastic material, (ii) a filler and (iii) a heat reactive coupling agent. The medical tubing can have a kink resistance no worse than a ...
|
|
WO/2023/074543A1 |
Provided is an elongated medical instrument on which a hydrogel film is formed using a simpler method. The elongated medical instrument comprises a base material and a swollen gel film that covers the base material, wherein the swollen g...
|
|
WO/2023/059319A1 |
The present disclosure relates to formulations for coating a balloon of a balloon catheter, the formulations including one or more groups of microparticles that include a therapeutic agent. In some aspects, the microparticles are polymer...
|
|
WO/2023/057947A1 |
The present invention discloses a method for preventing both the active and the passive early degeneration of prosthesis to be contacted with biological fluid.
|
|
WO/2023/059810A1 |
Materials, methods, and techniques herein relate to stents. More specifically, the instant disclosure relates to stents, such as catheters, for slow-release drug delivery of urological therapeutic agents.
|
|
WO/2023/059649A1 |
An example medical device includes a vascular device, such as a catheter, and an anti-thrombogenic coating on a surface of the vascular device, such as a surface likely to contact blood. The anti-thrombogenic coating includes one or more...
|
|
WO/2023/059318A1 |
The present disclosure concerns drug coating layers for medical devices that cover an exterior surface or portion thereof. The drug coating layers include a bioabsorbable material with a therapeutic or a polymer microparticle loaded with...
|
|
WO/2023/059536A1 |
Multilayer tubes including an inner layer and a tie layer are described. The inner layer includes a fluorinated polymer, and has an inner surface defining an inner diameter of the multilayer tube and an outer surface separated from the i...
|
|
WO/2023/055656A1 |
Some embodiments relate to additive manufactured articles having coated surfaces and related methods. The methods may comprise forming a three-dimensional (3D) article by additive manufacturing to obtain an additive manufactured 3D artic...
|
|
WO/2023/054500A1 |
This medical coating agent contains a polymer having a structural unit (A) derived from an ethylenic unsaturated monomer having an urethane bond. The polymer contained in the medical coating agent satisfies condition (i) in a case where ...
|
|
WO/2023/054499A1 |
This medical coating agent contains a polymer including a structural unit (A) derived from an ethylenically unsaturated monomer having a urethane bond. In a DSC curve obtained by including water into the polymer and increasing the temper...
|
|
WO/2023/054762A1 |
The present invention relates to a method for treating restenosis of a DES inserted after a BVS, comprising the step of inserting a balloon coated with an intimal hyperplasia inhibitor into the pathological blood vessel of a patient with...
|
|
WO/2023/037197A1 |
Flexible medical articles have a barrier polymer coating that provides a cleanable surface and reduced microbial touch transfer. The articles may be flat or tubular. The articles are formed from a polymer composition containing one or mo...
|
|
WO/2023/035046A1 |
Provided is a method of coating a substrate with a hyperbranched polyglycerol. The hyperbranched polyglycerol is formed by activating the surface of the substrate followed by polymerisation of monomers of glycidol, or derivatives thereof...
|
